Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials

1) To delineate latent classes of treatment response to biologics in juvenile idiopathic arthritis (JIA) patients in the first 16  weeks after initiation. 2) To identify predictors of early disease response.

Source: Pediatric Rheumatology - July 30, 2022 Category: Rheumatology Authors: Lily Siok Hoon Lim, Shamsia Shobhan, Armend Lokku, Sarah Ringold and Eleanor Pullenayegum Tags: Research article Source Type: research